German Cancer Prize 2026
The winner of the German Cancer Prize 2026 in the category “Health Services Research” is Professor Dr. med. Jochen Schmitt
Media release from Innovationsausschuss (IA):
German Cancer Prize 2026
The German Cancer Prize has been awarded annually since 1986 for outstanding work in German-speaking countries in the following categories:
-Experimental basic oncological research
-Translational research
-Tumor diagnostics and treatment
-Health services research
The winner of the German Cancer Prize 2026 in the category “Health Services Research” is Professor Dr. med. Jochen Schmitt from TU Dresden as head of the WiZen project funded by the Innovation Committee.
The WiZen project aims to assess the quality of care in certified organ cancer centers compared to non-certified hospitals. Based on (GKV) statutory health insurance billing data and cancer registry data, it has been shown that patients in certified centers have a survival advantage.
With his research, Prof. Dr. med. Schmitt demonstrates how healthcare research can directly improve practice:
- Through the development of new care models
- Methodological groundwork
- Testing of new evidence-based forms of care for patients
The results from WiZen provide important insights into the quality of cancer treatments in certified centers compared to other clinics and give patients guidance in choosing a clinic.
-The resulting insights are highly relevant for those affected, service providers, payers, health policy and society as a whole.
The Innovation Committee congratulates Professor Dr. med. Jochen Schmitt and the WiZen project team on their recognition and their crucial contribution to healthcare research in Germany.
Further information about the project can be found here:
innovationsfonds.g-ba.de/projekte/wizen
Innovationsausschuss (IA):
Photo: ©Jochen Schmitt
All rights belong to: (for this news)
Innovationsausschuss (IA) | G - BA | WiZen project & team | Prof. Dr. med. Jochen Schmitt
